The New Breast Exam That Nearly Quadruples Detection

A new breast imaging technique pioneered at the Mayo Clinic nearly quadruples detection rates of invasive breast cancers in women with dense breast tissue. Molecular Breast Imaging (MBI) is a supplemental imaging technology designed to find tumors that would otherwise be obscured by surrounding breast tissue on a mammogram. Tumors and dense tissue can both appear white on a mammogram, making tumors indistinguishable from background tissue in women with dense breasts. Having a dense breast tissue is not uncommon, about half of all screening-aged women have dense breast tissue. Thanks to MBI, detection rates have increased by more than 360% when used in addition to regular screening mammography. Dr. Michael K. O’Connor, one of the authors of the Mayo Study called “Molecular Breast Imaging at Reduced Radiation Dose for Supplemental Screening in Mammographically Dense Breasts” joins Medical Director Dr. Jay Harness. For more information on Molecular Breast Imaging, go to Gamma Medica: http://www.gammamedica.com/